Share Price
Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Investment Rating
-
Master Rating:
-
Bacil Pharma has an operating revenue of Rs. 1.53 Cr. on a trailing 12-month basis. An annual revenue de-growth of -14% needs improvement, Pre-tax margin of 0% needs improvement, ROE of -315% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 32% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 106 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Oper Rev Qtr Cr
- Operating Expenses Qtr Cr
- Operating Profit Qtr Cr
- Depreciation Qtr Cr
- Interest Qtr Cr
- Tax Qtr Cr
- Net Profit Qtr Cr
Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- 0.18
- 50 Day
- 0.18
- 100 Day
- 0.17
- 200 Day
- 0.15
- 20 Day
- 0.18
- 50 Day
- 0.18
- 100 Day
- 0.17
- 200 Day
- 0.15
Resistance and Support
- First Resistance
- 0.18
- Second Resistance
- 0.18
- Third Resistance
- 0.18
- First Resistance
- 0.18
- Second Resistance
- 0.18
- Third Resistance
- 0.18
- RSI
- 100
- MFI
- 61.26
Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- Week
- 1 Month
- 6 Month
Result Highlights
Synopsis
BSE-Medical-Generic Drugs
Bacil Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 6.53 Cr. for the Year ended 31/03/2021. Bacil Pharma Ltd. is a Public Limited Listed company incorporated on 08/05/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1987PLC043427 and registration number is 043427.- Market Cap
- 3
- Sales
- Shares in Float
- 0.34
- No of funds
- Yield
- Book Value
- 3
- U/D Vol ratio
- 1.7
- LTDebt / Equity
- Alpha
- -0.03
- Beta
- 0.43
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 42.67%
- 42.67%
- 42.67%
- Individual Investors
- 52.9%
- 52.84%
- 52.89%
- Others
- 4.43%
- 4.49%
- 4.44%
Management
- Name
- Designation
- Mr. Shirish Shetye
- Ind. Non-Executive Director
- Mr. Lalit Jain
- Ind. Non-Executive Director
- Mr. Prakash Shah
- Director
- Dr. Sneha Shah
- Non Executive Woman Director
Forecast
Price Estimates
FAQs
What is Share Price of ?
share price is ₹00 As on 20 August, 2022 | 09:49